Patients With Low HER2 Expression (IHC 1+ or IHC 2+/ISH-) and HER2 IHC 0 Advanced Breast Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Efficacy of Combined Peripheral Blood CTCs and Serum HER2 Detection in Docetaxel-based Treatment for HER2 Low-expression Breast Cancer (NCT07670182) | Tianjin Medical University Cancer Institute and Hospital | 2026-06-15 |
Track Patients With Low HER2 Expression (IHC 1+ or IHC 2+/ISH-) and HER2 IHC 0 Advanced Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.